16 reports

  • PRODUCTS UNDER DEVELOPMENT BY UNIVERSITIES/INSTITUTES, H2 2017 (CONTD..1), H2 2017
  • MALARIA - PIPELINE BY MICROBIOTIX INC, H2 2017

PK analysis demonstrated that ArTiMist was rapidly absorbed in children with severe or complicated falciparum malaria, or children with uncomplicated malaria with gastrointestinal complications.

  • Malaria
  • Research And Development
  • United States
  • Product Initiative
  • Sanaria Inc.
  • MALARIA - PIPELINE BY ZYDUS CADILA HEALTHCARE LTD, H1 2017
  • MALARIA - PIPELINE BY EISAI CO LTD, H1 2017

It also provides antibiotics used for treatment of diseases such as vascular diseases, deep venous thrombosis and gastrointestinal tract diseases.

  • Malaria
  • Research And Development
  • United States
  • World
  • Product Initiative
  • Malaria
  • Pharmaceutical
  • Vaccine
  • United States
  • GlobalData's company
  • DESIGNMEDIX, INC. - PIPELINE BY INDICATION, 2015

This report is a licensed product and is not to be photocopied DesignMedix, Inc. has promising clinical drug candidates for ## major therapeutic areas, Gastrointestinal and Infectious Disease.

  • Malaria
  • United States
  • World
  • Product Initiative
  • DesignMedix

The agreement enables the parameters to build a specialist company in the field of gastrointestinal pharmaceuticals.

  • Cancer
  • Malaria
  • Japan
  • United States
  • Eisai Co., Ltd.
  • Cerebral (Fatal) Malaria - Pipeline by Eisai Co Ltd, H2 2016

The company' s franchise areas in research include neurology, oncology, vascular and immunological reaction, gastrointestinal disorders, and musculoskeletal diseases.

  • Malaria
  • Pathology
  • World
  • Product Initiative
  • Eisai Co., Ltd.
  • GENEDRIVE - MALARIA ASSAY - PRODUCT DESCRIPTION
  • GENEDRIVE - MALARIA ASSAY - PRODUCT STATUS

It specializes in the marketing of epithelial stem cells in the areas of oncology, gastrointestinal diseases and dermatological applications.

  • Clinical Trial
  • Malaria
  • Point Of Care Testing
  • United States
  • GlobalData's company

DESIGNMEDIX INC Pharmaceuticals & Healthcare - Deals and Alliances Profile Report Code: GDPH##D Published: November 2017 DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases including malaria and diarrhea.

  • Healthcare
  • Malaria
  • Pathology
  • United States
  • DesignMedix

Report covers products from therapy areas Oncology, Infectious Disease and Gastrointestinal which include indications Malaria, Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Breast Cancer, Colon Cancer, Hepatocel

  • Malaria
  • Therapy
  • World
  • Product Initiative
  • Domainex Ltd
  • Clinical Trial profile. 367 Trial Title
  • Clinical Trial Profile Snapshots

Gastrointestinal Complications Superiority of ArTiMist Versus Quinine in Children with Severe Malaria GDCT## NCT##, ART## Infectious Disease Malaria Completed Phase III Interventional artemether Proto Pharma Pvt.

  • Clinical Trial
  • Infectious Disease
  • Malaria
  • World
  • GlaxoSmithKline plc

The company' s portfolio of marketed products treat central nervous system disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, women' s health issues, gastrointestinal diseases, hematological disorders, hormonal disorders and others.

  • Asthma
  • Health Care Provider
  • Malaria
  • Australia
  • GlobalData's company
  • Zydus Cadila Healthcare Enters into Agreement with Medicines for Malaria Venture

Cadila' s products find application in the treatment of disease related to gastrointestinal, cardiovascular, women' s healthcare, respiratory, pain management, cancer, inflammation and neurology, among others.

  • Malaria
  • Pharmaceutical
  • United States
  • Company Operations
  • GlobalData's company

(MERIDIAN) MANUFACTURES DIAGNOSTIC TEST KITS FOR RESPIRATORY, GASTROINTESTINAL, VIRAL AND PARASITIC INFECTIOUS DISEASES.

  • Infectious Disease
  • Malaria
  • United States
  • Company Financials
  • Meridian Bioscience Europe SA

The most common adverse events reported in the Phase I clinical trials were related to the central nervous system and the gastrointestinal system.

  • Malaria
  • R&D
  • Research And Development
  • United States
  • Eisai Co., Ltd.

Gastrointestinal, Infectious Disease, Musculoskeletal Disorders, Oncology, Respiratory, Immunology, Metabolic Disorders, Dermatology and Ear Nose Throat Disorders.

  • Malaria
  • R&D
  • Research And Development
  • United States
  • Cellceutix Corporation

Budesonide (Entocort, Entocort EC) is a gastrointestinal agent.

  • Cancer
  • Malaria
  • Therapy
  • United States
  • AstraZeneca PLC